Broken beyond repair: self regulation of industry payments to clinicians and hospitals

Piotr  Ozieranski; Shai Mulinari

doi:10.1136/bmj.q1559

Broken beyond repair: self regulation of industry payments to clinicians and hospitals

Piotr Ozieranski, Shai Mulinari

Sociology

University of Bath

Research output: Contribution to journal › Debate/Note/Editorial

Abstract

The latest Novo Nordisk revelations provide the strongest argument yet for a Sunshine Act for drug and medical device companies operating in the UK

Original language	English
Article number	q1559
Journal	BMJ: British Medical Journal
Volume	386
DOIs	https://doi.org/10.1136/bmj.q1559
Publication status	Published - 2024 Jul 12

Subject classification (UKÄ)

Sociology (excluding Social Work, Social Psychology and Social Anthropology)
Health Care Service and Management, Health Policy and Services and Health Economy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bmj.q1559Licence: CC BY-ND

Following the money: cross-national study of pharmaceutical industry payments to medical associations and patient organisations
Mulinari, S. (Researcher) & Ozieranski, P. (Researcher)
2021/01/01 → 2024/05/31
Project: Research

Cite this

@article{f4013f1838734dcb9f97fdeb80756183,

title = "Broken beyond repair: self regulation of industry payments to clinicians and hospitals",

abstract = "The latest Novo Nordisk revelations provide the strongest argument yet for a Sunshine Act for drug and medical device companies operating in the UK",

author = "Piotr Ozieranski and Shai Mulinari",

year = "2024",

month = jul,

day = "12",

doi = "10.1136/bmj.q1559",

language = "English",

volume = "386",

journal = "BMJ: British Medical Journal",

issn = "1756-1833",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Broken beyond repair: self regulation of industry payments to clinicians and hospitals

AU - Ozieranski, Piotr

AU - Mulinari, Shai

PY - 2024/7/12

Y1 - 2024/7/12

N2 - The latest Novo Nordisk revelations provide the strongest argument yet for a Sunshine Act for drug and medical device companies operating in the UK

AB - The latest Novo Nordisk revelations provide the strongest argument yet for a Sunshine Act for drug and medical device companies operating in the UK

U2 - 10.1136/bmj.q1559

DO - 10.1136/bmj.q1559

M3 - Debate/Note/Editorial

C2 - 38997125

SN - 1756-1833

VL - 386

JO - BMJ: British Medical Journal

JF - BMJ: British Medical Journal

M1 - q1559

ER -

Broken beyond repair: self regulation of industry payments to clinicians and hospitals

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Projects

Following the money: cross-national study of pharmaceutical industry payments to medical associations and patient organisations

Cite this